by Cara MurezMost folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay.Scientists have discove
by Cara MurezMost folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay.Scientists have discove
by Claes Björnberg,Umea UniversityCredit: Pixabay/CC0 Public DomainMany risk factors for multiple sclerosis (MS), which causes damage to the central nervous system, have been identified. However
by Claes Björnberg,Umea UniversityCredit: Pixabay/CC0 Public DomainMany risk factors for multiple sclerosis (MS), which causes damage to the central nervous system, have been identified. However
byHiroshima UniversityCredit: Andrea Piacquadio/PexelsJust as computer devices acting differently can hint at the possibility of malware lurking in the background, changes in brain patterns that
byHiroshima UniversityCredit: Andrea Piacquadio/PexelsJust as computer devices acting differently can hint at the possibility of malware lurking in the background, changes in brain patterns that
byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainPeople who have more disrupted sleep in their 30s and 40s may be more likely to have memory and thinking problems a decade later,
byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainPeople who have more disrupted sleep in their 30s and 40s may be more likely to have memory and thinking problems a decade later,
by University of California, Los AngelesCredit: CC0 Public DomainA new stem cell-based treatment for progressive dementia just took a big step closer to the clinic.UCLA researchers have successfu
by University of California, Los AngelesCredit: CC0 Public DomainA new stem cell-based treatment for progressive dementia just took a big step closer to the clinic.UCLA researchers have successfu
by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to
by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to
by Bob Yirka , Medical XpressSample, workflow, and phylogeny. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado2733An international team of neuroscientists and anthropologists has fou
by Bob Yirka , Medical XpressSample, workflow, and phylogeny. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado2733An international team of neuroscientists and anthropologists has fou
by National Institutes of HealthColorized scanning electron micrograph of a T lymphocyte (also known as a T cell) (blue). Credit: NIAIDEvidence from a small-scale clinical trial suggests that a v
by National Institutes of HealthColorized scanning electron micrograph of a T lymphocyte (also known as a T cell) (blue). Credit: NIAIDEvidence from a small-scale clinical trial suggests that a v
by Jonathan Ka Long Mak and Sara Hägg,The ConversationCredit: CC0 Public DomainAs we journey through life, the risk of developing chronic diseases, including cancer, heart disease and neurologic
by Jonathan Ka Long Mak and Sara Hägg,The ConversationCredit: CC0 Public DomainAs we journey through life, the risk of developing chronic diseases, including cancer, heart disease and neurologic
by Radiological Society of North America(A) Cerebral microbleeds (CMB) visualized as round, dark lesions (arrow) on SWI sequence in the left temporal lobe in a migraine case with aura. (B) Asymme
by Radiological Society of North America(A) Cerebral microbleeds (CMB) visualized as round, dark lesions (arrow) on SWI sequence in the left temporal lobe in a migraine case with aura. (B) Asymme